SCHEMBL21067139

SCHEMBL21067139

Cc1cc(CNc2ccnc3cn[nH]c23)n[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 5/20 0.45
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C8 P10632 2/20 0.44
▸ HTT P42858 1/20 0.37
▸ PTK2 Q05397 1/20 0.37
▸ HTR1A P08908 4/20 0.37
▸ ADRA1D P25100 4/20 0.37
▸ ADRA1A P35348 4/20 0.37
▸ ADRA1B P35368 4/20 0.37
▸ PDE1A P54750 5/20 0.36
▸ PDE1B Q01064 5/20 0.36
▸ PDE1C Q14123 5/20 0.36
▸ PKM P14618 1/20 0.35
▸ IGF1R P08069 2/20 0.35
▸ FGFR1 P11362 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ IDO1 P14902 1/20 0.34
▸ TDO2 P48775 1/20 0.34
▸ RIPK2 O43353 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067168 0.82 TGFBR1 (0.40) TGFBR1CYP3A4CYP2C8HTTPTK2
SCHEMBL21067122 0.82 TGFBR1 (0.42) TGFBR1CYP3A4CYP2C8HTTPTK2
SCHEMBL21067153 0.81 TGFBR1 (0.40) TGFBR1CYP3A4CYP2C8HTR1AADRA1D
SCHEMBL21067266 0.80 TGFBR1 (0.39) TGFBR1CYP3A4CYP2C8HTR1AADRA1D
SCHEMBL21067262 0.79 TGFBR1 (0.40) TGFBR1CYP3A4CYP2C8HTTPTK2
SCHEMBL21067172 0.79 TGFBR1 (0.40) TGFBR1CYP3A4CYP2C8HTTPTK2
SCHEMBL22734376 0.78 IDO1 (0.52) CYP3A4HTTHTR1AADRA1DADRA1A
SCHEMBL21067211 0.78 MAP4K4 (0.39) TGFBR1CYP3A4CYP2C8HTR1AADRA1D
SCHEMBL21061229 0.78 SYK (0.46) TGFBR1CYP3A4CYP2C8HTTPKM
SCHEMBL21067190 0.77 TGFBR1 (0.41) TGFBR1CYP3A4CYP2C8HTR1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200375950-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS H. LUNDBECK A/S (DK) 2020-12-03 — — US disclosed
US-10766893-B2 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors H. LUNDBECK A/S (DK) 2020-09-08 — — US disclosed
US-20190194189-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS H. LUNDBECK A/S (DK) 2019-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200375950-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS PDE12, PDE3A, PDE5A TGFBR1 1214/4885CYP3A4 648/4885CYP2C8 1375/4885
US-10766893-B2 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors PDE12, PDE3B, PDE5A TGFBR1 1330/4885CYP3A4 573/4885CYP2C8 1563/4885
US-20190194189-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS PDE12, PDE3B, PDE5A TGFBR1 1330/4885CYP3A4 573/4885CYP2C8 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback